The four-day conference is organized by Dr. Josef M. Penninger of the Institute of Molecular Biotechnology GmbH and Dr. Kym Boycott of Canada’s CHEO Research Institute and will take place in the IMP Lecture Hall. The conference will examine the current and future bottlenecks to gene discovery, disease modeling, and therapeutic approaches for the estimated 7,000 known rare diseases, and suggest strategies to accelerate progress in this regard.
For more information on the program, speakers and deadlines, and to submit an abstract or register, please visit www.keystonesymposia.org/18S4. Scholarships are available for students and postdocs. In addition, learn more about the conference by watching a video interview with Dr. Penninger at http://bit.ly/KSpenninger.